Javed Butler, MD, MPH, MBA, is the Patrick A. Lehan Professor and Chairman of the Department of Medicine Department at University of Mississippi. He is also Professor of Physiology and Biophysics. Prior to joining the University of Mississippi, he was Charles A. Gargano Professor and Director of the Division of Cardiovascular Medicine and Co-Director of the Heart Institute at Stony Brook University, New York. He had served as the Director for heart failure research at Emory University and Director of the heart and heart-lung transplant programs at Vanderbilt University prior to that.

In this week's Homerun Slides, looking at multiple daily injections while using CGM.

This chapter will concentrate on the monogenic disorders of the beta cell that account for 1–2% of diabetes. They are discrete disorders, which are a significant cause of diabetes in their own right. Correct molecular diagnosis is important to predict clinical course, explain other associated clinical features, enable genetic counseling, diagnose family members, and most importantly guide appropriate treatment. In addition to this clinical importance, the discovery and study of monogenic disorders has given further insight into the physiology and pathophysiology of the beta cell.

In this Exclusive Interview transcript, Javed Butler talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about the relationship between diabetes and heart failure, the importance of managing patients' cardio risks as well as A1C, and increasing attention to heart failure outcomes.

In this Exclusive Interview, Javed Butler talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about the importance of managing patients' cardio risks as well as A1C, and increasing attention to heart failure outcomes.

In part 1 of this Exclusive Interview, Javed Butler talks with Diabetes in Control Publisher Steve Freed about the use of SGLT to lower risk of heart disease.

In part 2 of this Exclusive Interview, Javed Butler talks with Diabetes in Control Publisher Steve Freed about the four most important treatment goals when helping a patient who has diabetes.

In part 3 of this Exclusive Interview, Javed Butler explains the focus on heart disease versus diabetes as a major cause of mortality in a conversation with Diabetes in Control Publisher Steve Freed.

In part 4, the conclusion of this Exclusive Interview, Javed Butler talks with Diabetes in Control Publisher Steve Freed about the use of SGLT2 to help prevent heart failure but not as a current treatment method.

Now that the Mid-term elections are, for all purposes, over with, we all know that there has been a change in leadership in the Congress. High on Congress’s agenda is the high cost of prescription drug prices, and we expect to see some pressure from the House to lower these …